Quick Research
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Indonesia
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 29,572 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
DLD, upregulated by YY1, fuels glioblastoma multiforme progression via EphA2 phosphorylation to activate PI3K/AKT/mTOR (2026-03-09)
Journal: QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2026) IF: 6.4Products Cited: Fetal Bovine Serum -
Multi-omics Mendelian randomization revealing SEMA7A as potential drug target for facial skin aging (2026-01-20)
Journal: Journal of Big Data (2026) IF: 6.4Products Cited: Hacat Cells Line, NIH/3T3 Cells Line -
Allicin-based biomimetic nanoparticles of the erythrocyte membrane for delivery of lumefantrine to enhance its antimalarial effect (2026-01-11)
Journal: International Journal of Pharmaceutics-X (2026) IF: 6.4Products Cited: RPMI-1640 Medium, Phosphate Buffer (PBS, 1 ×) -
GPC3 and CD133-targeted peptide dual modification enhances the therapeutic effect of doxorubicin carried by OMVs on hepatocellular carcinoma (2026-02-24)
Journal: International Journal of Pharmaceutics-X (2026) IF: 6.4Products Cited: RAW 264.7 Cells Line, HuH-7 Cells Line -
Engineered M2 macrophage-derived vesicles deliver DNase I for cfDNA clearance and multi-organ protection in sepsis (2026-03-26)
Journal: International Journal of Pharmaceutics-X (2026) IF: 6.4Products Cited: Human Umbilical Vein Endothelial Cells -
Biomass fuel assisted green synthesis of defect-rich MgO nanoparticles for antimicrobial and biocompatibility studies (2026-03-19)
Journal: JOURNAL OF ALLOYS AND COMPOUNDS (2026) IF: 6.3Products Cited: MC3T3-E1 Subclone 14 Cells Line -
Mitophagy-mediated ferroptosis involved in 2,5-hexanedione-induced neurotoxicity in rats (2026-02-04)
Journal: Journal of Environmental Sciences (2026) IF: 6.3Products Cited: SH-SY5Y Cells Line -
Circular RNA circDNAJC5 Regulates Ultrafine Particle–Disrupted Microglial Lipid Metabolism via the Sphingolipid Signaling Pathway (2026-02-23)
Journal: Environment & Health (2026) IF: 6.3Products Cited: HMC3 Cells Line, MEM Medium, DMEM (High glucose) Medium, BV2 Cells Line -
Calycosin Targets the CYP1B1-AKT/SP1-GPX4 Axis to Modulate Ferroptosis in Colorectal Carcinogenesis (2026-01-06)
Journal: PHYTOTHERAPY RESEARCH (2026) IF: 6.3DOI: 10.1002/ptr.70172Products Cited: HT-29 Cells Line, 293 Cells Line, MEM (ATCC modified) Medium -
Ingenol-Mediated SIRT1-LXRα Signaling Reduces Lipid Accumulation and Alleviates Postmenopausal Liver Damage (2026-01-13)
Journal: PHYTOTHERAPY RESEARCH (2026) IF: 6.3DOI: 10.1002/ptr.70195Products Cited: Hep G2 Cells Line
